Scientific & medical advisory board
Our esteemed board plays a pivotal role in shaping the direction of our research, offering invaluable guidance and thoughtful insight as we work to advance our understanding of this disease. Their expertise, leadership, and unwavering commitment ensure that our efforts remain focused, strategic, and impactful. We deeply appreciate the time, dedication, and hard work they invest in this mission, as their contributions are instrumental in driving meaningful progress. It is through their vision and support that we are able to pursue innovative solutions, improve patient outcomes, and ultimately bring hope to those affected by Gould Syndrome.
Board members are listed in alphabetical order of their surname.
-
Tom Van Agtmaeil, PhD
Professor of Matrix Biology and Disease (Cardiovascular and Metabolic Health)
University of Glasgow, Scotland
-
Kenda Alhadid, MD, MSC, FRCPC
Vascular and Pediatric Neurologist with a special interest in stroke in the young, stroke in women, and genetic vasculopathies
Massachusetts General Hospital, Boston
-
Brenda L. Bohnsack, MD, PhD
-
Thibault Coste, PhD
-
Douglas Gould, PhD
Professor, Genetics, Ophthalmology, Leading Researcher in COL4A1 & COL4A2
San Francisco, California
-
Arshad Majid, MD
Vascular and Interventional Neurologist
Professor of Cerebrovascular Neurology
University of Sheffield, England
-
Hugh Markus, PhD
-
Patricia L. Musolino, MD, PhD
-
John Snow, MD, PhD
Neurology Resident
Massachusetts General Hospital, Boston
-
Rachel Vassar, MD